# Hypofractionated Stereotactic Boost in Prostate Cancer

> **NCT01596816** · PHASE2 · COMPLETED · sponsor: **Centre Oscar Lambret** · enrollment: 76 (actual)

## Conditions studied

- Cancer

## Interventions

- **RADIATION:** First part of treatment : Conformal irradiation
- **PROCEDURE:** Fiducials placement
- **RADIATION:** Second part : hypofractionated stereotactic boost

## Key facts

- **NCT ID:** NCT01596816
- **Lead sponsor:** Centre Oscar Lambret
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08-31
- **Primary completion:** 2016-09
- **Final completion:** 2018-09-01
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2026-03-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01596816

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01596816, "Hypofractionated Stereotactic Boost in Prostate Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01596816. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*